Define the biological system
Specify cardiac and supporting cell populations, source, maturity and the material environment.
Application pathway: cardiac and safety research
Connect structure and function to a defined readout.
Cardiac model development requires more than contractile cells. The biological composition, architecture, culture conditions, measurement method and repeatability plan must all serve the research question.
Start from function
What must the culture do, and how will you measure it?
A structured culture is valuable only when it supports a relevant, interpretable endpoint. Define function, timing, instrumentation and controls before choosing the print process.
Select the readout
Choose the functional, structural or molecular measurement and its sampling schedule.
Set the use boundary
State whether the work explores model development, biological mechanism or a selected safety question.
High-cell-density development
Build the architecture around the assay.
ReJI can form and deposit cell-laden gels through reactive jet impingement. A cardiac application still requires model-specific work on cell preparation, hydrogel composition, geometry, culture, handling and the selected measurement system.
- Cell source, maturity and preparation
- Hydrogel composition and cell density
- Construct shape, thickness and nutrient access
- Culture duration and stimulation conditions
- Functional readout, controls and repeatability
Evidence pathway
Published cardiac work provides a foundation, not a finished assay.
A 2026 peer-reviewed paper reports ReJI-bioprinted high-cell-density cardiac constructs with sustained contractile function. The associated dataset is openly available through Newcastle University. Further evidence is needed for any specific compound-testing or safety-pharmacology use.
Read the peer-reviewed cardiac publicationReview the supporting research dataset
JetBio does not claim that the published construct is a regulator-qualified safety assay, a replacement for all animal studies or a validated predictor of clinical outcomes.
Feasibility questions
Define the evidence before testing compounds.
What response is expected?
Define the control behaviour and the direction, scale and timing of a meaningful response.
What model variation is acceptable?
Set criteria for construct dimensions, cell distribution, baseline function and culture performance.
How will exposure work?
Specify dosing route, concentration range, duration, sampling and relevant material interactions.
Can the workflow transfer?
Consider operators, plate handling, instrumentation, analysis and repeatability across intended settings.
Related guidance
Place the application in its research context.
Research model development
Explore application fit, modularity and a staged feasibility route for academic or institute work.
Visit the researcher journeyDrug-discovery use
Define context of use, performance, robustness, scale and the evidence needed for programme adoption.
Read the drug-discovery guideStart a useful conversation
Define the cardiac question and readout.
Share the cells, architecture, assay, controls and evidence threshold. JetBio will assess whether a scoped development project is credible.